This review is describing the diagnostic and therapeutic approach to tracheobronchial involvement in relapsing polychondritis (RP), with a focus on differential diagnoses of inflammatory origin.
Hosted on MSN5mon
FDA grants marketing authorisation to Peytant’s AMStent systemPeytant Solutions has received marketing authorisation from the US Food and Drug Administration (FDA) for its AMStent tracheobronchial covered stent system. This novel therapy platform is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback